Canakinumab relieves symptoms of acute flares and improves health-related quality of life in patients with difficult-to-treat Gouty Arthritis by suppressing inflammation: results of a randomized, dose-ranging study (Q35092969)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Canakinumab relieves symptoms of acute flares and improves health-related quality of life in patients with difficult-to-treat Gouty Arthritis by suppressing inflammation: results of a randomized, dose-ranging study |
scientific article |
Statements
1 reference
Canakinumab relieves symptoms of acute flares and improves health-related quality of life in patients with difficult-to-treat Gouty Arthritis by suppressing inflammation: results of a randomized, dose-ranging study (English)
1 reference
Naomi Schlesinger
1 reference
Marc De Meulemeester
1 reference
Andrey Pikhlak
1 reference
A Eftal Yücel
1 reference
Dominik Richard
1 reference
Valda Murphy
1 reference
Udayasankar Arulmani
1 reference
Peter Sallstig
1 reference
Alexander So
1 reference
25 March 2011
1 reference
1 reference
25 March 2011
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference